STRATA CRITICAL MEDICAL INC CLASS (SRTA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SRTA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SRTA | Director | 40 | ["Co-Founder and Managing Partner of Maple Park Capital Partners","Partner at RedBird","Vice President of BDT & Company LLC","Associate at Flexpoint Ford, LLC","Analyst at Goldman Sachs","Chairman of the Board of Directors of Vogel Alcove","Trustee at Good Shepherd Episcopal School of Dallas"] | ["Audit Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Andrew C. Lauck has served as one of our directors since [date not specified in excerpt]. Mr. Lauck became Chairman of the Audit Committee on August 1, 2025. The Board has appointed Mr. Lauck, an independent director, to serve as Lead Independent Director, effective immediately following the 2026 Annual Meeting and assuming his election at the annual meeting. Mr. Lauck will succeed Mr. Affeldt, who is not standing for re-election. Following the 2026 Annual Meeting, the Board expects that Mr. Lauck will join the Compensation Committee and that Mr. Lauck will join the Nominating and Corporate Governance Committee. Our Board has determined that Mr. Lauck qualifies as an audit committee financial expert as such term is defined in Item 407(d)(5) of Regulation S-K and meets the financial sophistication requirements of the Nasdaq listing standards.